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NephrotoxicityAbstract The present study aims to evaluate the possible protective role of polysaccharides
extracted from the Egyptian mango Mangifera indica L. (MPS) and silymarin against cyclophos-
phamide (CP) nephrotoxicity in male albino rats. Male rats were randomly divided into, control
group (administered distilled water orally for 10 days) and MPS (500, 1000 mg/kg, p.o.) and/or sily-
marin (150 mg/kg, p.o.) treated groups for 10 days. In the last 5 days of treatment rats were admin-
istered CP (150 mg/kg, i.p). The MPS revealed significant prophylactic effect against kidney injury
induced by CP as demonstrated by enhancement of the kidney function via decreasing serum cre-
atinine, urea and uric acid. Treatment of rats with MPS extract and/or silymarin significantly
increased the level of reduced glutathione (GSH) and superoxide dismutase (SOD) activity while
decreased the level of total malondialdehyde (MDA) and glutathione-S-transferase (GST). Also,
histopathological examinations confirmed the protective efficacy of MPS and/or silymarin against
CP nephrotoxicity. In conclusion, the obtained results of the present study support the protective
antioxidant role of MPS and/or silymarin against CP-induced kidney disorder in rats.
 2015 The Egyptian German Society for Zoology. Production and hosting by Elsevier B.V. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
The kidney is a primary target for numerous toxic xenobiotics
including drugs, environmental chemicals and metals. Acute
kidney injury, induced by drugs and other stimuli, is a signifi-cant clinical problem, and accounts for the cessation of devel-
opment of many promising drug candidates Shelton et al.
(2013). Drug-induced nephrotoxicity is an extremely common
condition and is responsible for a variety of pathological
effects on the kidneys Dhodi et al. (2014). Cyclophosphamide
(CP) is a potent anticancer agent. CP is effective against a wide
spectrum of malignancies, such as leukemia, lymphoma,
breast, lung, prostate, and ovarian cancers Khan et al.
(2004). The usage of CP is severely limited by its physiological
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ity, cardiotoxicity and myelosuppression Motawi et al.
(2010), Lameire et al. (2011) and Newton (2012). However,
its clinical use is restricted because of its marked organ toxicity
associated with increased oxidative stress and inflammation
Nafees et al. (2015). Oxidative stress is reported to play impor-
tant roles in CP-induced renal damage Abraham and Rabi
(2011). Renal damage is one of the dose-limiting side effects
of CP Abraham and Rabi (2011). It has been demonstrated
that increased generation of reactive oxygen species (ROS)
by CP in kidney tissues plays a critical role in the pathogenesis
of CP-induced kidney damage Stankiewicz and Skrzydlewska
(2003) and Abraham and Rabi (2009). So, free radical scav-
engers and antioxidants can be used in the treatment Sabolic
(2006). Cyclophosphamide is now being used in combination
with various detoxifying and protective agents with the pur-
pose of reducing or eliminating its adverse toxic effects
Neboh and Ufelle (2015) and Nurrochmad et al. (2015).
Silymarin, a bioflavonoid, is the main constituent of Sily-
bummarianum (milk thistle). Chemically, silymarin is a
flavonolignan that consists of a mixture of mainly three flavo-
noids, silibinin, silydianin and silychristin Kiruthiga et al.
(2007). Silymarin has been reported to possess several pharma-
cological activities including antioxidant and anti-inflamma
tory/immunomodulatory Manna et al. (1999), antifibrotic
Crocenzi and Roma (2006), hepatoprotective, antibacterial,
antiallergic, antimutagenic, antiviral, antithrombotic and
vasodilatory actions Wellington and Jarvis (2001). Many stud-
ies reported that silymarin reduced CP-induced ROS genera-
tion Jnaneshwari et al. (2012). Silymarin was shown to have
positive effects on preventing or decreasing severity of
cyclophosphamide nephrotoxicity Eser et al. (2012). So it is
the positive control used in this study.
Pharmacotherapy using natural substances can be currently
regarded as a very promising future alternative to conventional
therapyWang et al. (2013). Plants have been themajor source of
therapeutic agents for curing the human diseases Zahid et al.
(2013). Mango (Mangifera indica L.) is one of the most impor-
tant and popular tropical fruits, mainly due to its attractive fla-
vor Chen et al. (2012).M. indica L. is an important member of
the family Anacardiaceae and belongs to genusMangifera order
sapindales Ross (1999). In recent years, some bioactive polysac-
charides isolated from natural sources have attracted much
attention in the field of biochemistry and pharmacology Wang
et al. (2013) andXue et al. (2015). Some polysaccharides isolated
from natural sources show various important biological
activities, such as antitumor, immunomodulatory, and
anti-inflammatory effects, which are strongly affected by their
chemical structures and chain conformations Liu et al. (2015).
It has been well documented that polysaccharides increase
immunity through production of interleukins and antibodies
Yang et al. (2008) and therefore could be explored as novel
prospective antioxidants Sun et al. (2010) and Chen et al.
(2012). Polysaccharides can be currently regarded as a very
promising future alternative to conventional therapy in kidney
diseases Chiu et al. (2014) and Lu et al. (2014). When multiple
antioxidants are used in combination, they protect against
vulnerability to other agents and synergistically potentiate their
antioxidant properties Aleisa et al. (2013). So, the present study
was designed to evaluate the efficacy of polysaccharides
extracted from the mango pulp (MPS) and/or silymarin against
renal injury induced by cyclophosphamide in male albino rats.Materials and methods
Chemicals and reagents
Methanol 95%, ethanol, absolute acetone, and cyclophos-
phamide (Endoxan) were purchased from Bexter Oncology
GmbH (Germany), silymarin was purchased from SEDICO
Pharmaceutical Co. (6 October City, Egypt). All other chemi-
cals were of analytical grade. Kits for all biochemical parame-
ters were purchased from Biodiagnostic Company (El-Dokki,
Giza, Egypt).
Collection of Mangifera indica L.
Mature green mango (M. indica L.) cv. Fagrkelan fruits were
freshly harvested from Egypt fields through a local Dealer in
September 2012, M. indica washed thoroughly with running
tap water, seeds and peels are removed from mango.
Extraction of polysaccharides from Mangifera indica L.
Polysaccharides extracted from mango pulp by the technique
described by Devaki et al. (2009) with some modifications.
Briefly, 1670 g of mango pulp was boiled in 16.7 L of distilled
water at 100 C for 3 h. The slurry was separated by gauze and
then, was filtered. The filtrate was dialyzed against tap water
for 48 h, and then concentrated to about 350 ml under reduced
pressure using rotary evaporator. Then, the concentrated fil-
trate was precipitated using four volumes of 95% ethanol to
one volume of the extract (about 1400 ml 95% ethanol). The
extract was washed with absolute acetone, filtrated and then
dried in a vacuum desiccator over anhydrous calcium chloride.
About 65 g of polysaccharides extract is obtained and used for
animals’ experiments.Animals
The experimental animals used in this study were adult male
albino Wistar rats (Rattus norvegicus) weighing (150–160
± 5 g). The animals were obtained from the National
Research Center (NRC, Dokki, Giza). Animals were grouped
and housed in polyacrylic cages (Five animals per cage). Ani-
mals were given food and water ad libitum. Rats were main-
tained in a friendly environment with a 12 h/12 h light–dark
cycle at room temperature (22–25 C). Rats were acclimatized
to laboratory conditions for 7 days before commencement of
the experiment. The protocol was approved by the Cairo
University, Faculty of Science Institutional Animal Care and
Use Committee (IACUC), Egypt (CUFS/S/PHY/28/14), and
all the experimental procedures were carried out in accordance
with international guidelines for care and use of laboratory
animals.
Toxicity study (OECD 420)
Adult male albino rats (R. norvegicus) weighing (150–160
± 5 g) were used for acute toxicity studies. The rats were
divided into control and test groups containing five animals
each. The rats were administered orally with polysaccharides
extract of mango at dose levels of 5000 mg/kg (high dose)
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same amount of vehicle (distilled water) only. Rats were
observed carefully for 24 h after extract administration and
then for the next 14 days. At the end of this experimental per-
iod, the rats were observed for signs of toxicity, morphological
behavior, and mortality. Acute toxicity was evaluated based
on the number of deaths (if any). Acute toxicity was calculated
as per Organization for Economic Co-operation and Develop-
ment (OECD) guidelines 420 (Fixed dose method) (Van den
Heuvel et al., 1990; Whitehead and Curnow, 1992).
Experimental design
Thirty-five rats were randomly divided into seven groups (5 ani-
mals/group) as follows: Group 1: Served as a control group.
Group 2: Rats were administered distilled water (2 ml) orally
for 10 days. Group 3: Rats treated orally with MPS (dissolved
in distilled water) in a dosage of 500 mg/kg body weight for
10 days. Group 4: Rats treated orally with MPS in a dosage of
1000 mg/kg body weight for 10 days. Group 5: Rats treated
orally with silymarin (dissolved in distilled water) in a dosage
of 150 mg/kg body weight for 10 days. Group 6: Rats treated
orally with MPS in a dosage of 500 mg/kg body weight and
silymarin 150 mg/kg body weight at the same time for
10 days. Group 7: Rats treated orally with MPS in a dosage of
1000 mg/kg body weight and silymarin 150 mg/kg body weight
at the same time for 10 days (see Fig. 1).Rats of all groups except
group one treated intraperitoneally with CP in a dosage of
150 mg/kg body weight in the last 5 days (Jnaneshwari et al.,
2012).
Experimental procedures
After 10 days of treatment, the animals were fasted overnight
(12–14 h). Rats of each group were sacrificed by exsanguina-
tions under sodium pentobarbital anesthesia, and the blood
samples were collected from each animal into sterilized cen-
trifuge tubes for serum separation. Kidney was removed and
immediately blotted using filter paper to remove traces of
blood. The first part was immersed in 10% formal saline solu-
tion for fixation preparatory histopathological examinations.
The other part of kidney was stored at 80 C for biochemical
analysis. Blood samples were centrifuged at 3000 rpm for
15 min. Serum was separated and stored in Eppendorf at
20 C to be used for biochemical analysis. The kidney was
homogenized (10% w/v) in ice cold 0.1 M phosphate buffer
(pH 7.4). The homogenate was centrifuged at 3000 rpm for
15 min at 4 C and the resultant supernatant was used for esti-
mation of oxidative stress markers.
Assessment of serum biochemical parameter
All kits for biochemical analysis were purchased from Biodiag-
nostic Company. Determination of serum creatinine according
to colorimetric method was described by Tietz and Andresen
(1986). Urea was determined in serum by modified urease-
Berthlot method according to Tietz et al. (1990). Serum uric
acid was determined colorimetrically according to Tietz (1990).Assessment of oxidative stress markers
Oxidative stress markers were detected in the resultant super-
natant of kidney homogenate by using Biodiagnostic kits.
Lipid peroxide (Malondialdehyde) MDA was determined in
tissue according to Ohkawa et al. (1979). Reduced glutathione
(GSH) was determined in tissue according to Beutler et al.
(1963). Superoxide dismutase (SOD) activity was determined
according to Nishikimi et al. (1972). Glutathione-S-
transferase (GST) activity was determined according to
Habig et al. (1974).Histopathological analysis
Histological sections (4 lm thick) were prepared from paraffin
blocks of kidney tissues fixed in 10% formal saline. Sections
were stained with hematoxylin and eosin (H&E) (Mayer,
1903) and then, examined under light microscope under
400 magnifications.Statistical analysis
Values were expressed as mean ± SEM. (standard error) to
evaluate differences between the groups studied, a one way
analysis of variance (ANOVA) with the Duncan post hoc test
was used to compare the group means and P< 0.05 was con-
sidered statistically significant. SPSS for Windows (version
19.0) was used for the statistical analysis.Results
Toxicity study
Nevertheless, none of the five rats of the test group died and
did not show any sign of toxicity after administration of
MPS at higher dosage (5000 mg/kg) in the first 24 h or during
the experiment period (14 day) and the activities of serum
ALAT and serum ASAT are at normal range compared with
the control group. In addition, there is no histopathological
change in both liver and kidney. The single lethal dose of
MPS that kills half of the animals (LD50) was therefore taken
as above 2000 mg/kg. MPS is tested at two dosage levels (500
and 1000 mg/kg) as they represented 1/10th and 1/5th of the
proposed LD50.Improvement of kidney function in M. indica polysaccharides
(MPS) extract and/or silymarin treated rats
As shown in (Table 1), serum creatinine, urea and uric acid
levels were significantly increased (P< 0.05) following admin-
istration of CP compared to the control group. However,
treatment with MPS (500, 1000 mg/kg) and/or silymarin signif-
icantly showed enhancement in the recorded kidney function
markers.
Figure 1 Schematic diagram shows the experimental design of treatment.
Table 1 Effect of Mangifera indica polysaccharides (MPS) extract and/or silymarin on kidney functions parameter in serum of
cyclophosphamide (CP) – treated rats.
Groups Serum creatinine (mg/dL) Serum urea (mg/dL) Serum uric acid (mg/dL)
Control 57 ± 2.54a 123.34 ± 5.03bc 3.442 ± 0.108a
CP Vehicle(saline) 81 ± 1.87d 219.18 ± 11.74d 4.406 ± 0.135b
MPS (500 mg/kg) 69.2 ± 1.41c 94.16 ± 5.37a 3.3 ± 0.133a
MPS (1000 mg/kg) 71.5 ± 1.87c 102.52 ± 1.02ab 3.328 ± 0.058a
Silymarin 63.5 ± 4.71abc 127.5 ± 13.42c 3.19 ± 0.081a
MPS (500 mg/kg)silymarin 68 ± 2.427bc 104.16 ± 5.43abc 3.438 ± 0.132a
MPS (1000 mg/kg) + silymarin 60.7 ± 1.72ab 113.34 ± 3.58abc 3.272 ± 0.086a
Values are given as mean ± SEM for 5 rats in each group. Values with different superscript letters are significantly different at P< 0.05.
Figure 2 Effect of Mangifera indica polysaccharides (MPS)
extract and/or silymarin on kidney malondialdehyde (MDA) in
serum of cyclophosphamide (CP) – treated rats. Values are given
as mean ± SEM for 5 rats in each group. Values with different
superscript letters are significantly different at (P< 0.05).
Figure 3 Effect of Mangifera indica polysaccharides (MPS)
extract and/or silymarin on kidney glutathione reduced (GSH) in
serum of cyclophosphamide (CP) – treated rats. Values are given
as mean ± SEM for 5 rats in each group. Values with different
superscript letters are significantly different at (P< 0.05).
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Figure 5 Effect of Mangiferaindica polysaccharides (MPS)
extract and/or silymarin on kidney glutathione-S-transferase
(GST) in serum of cyclophosphamide (CP) – treated rats. Values
are given as mean ± SEM for 5 rats in each group. Values with
different superscript letters are significantly different at
(P< 0.05).
Figure 4 Effect of Mangifera indica polysaccharides (MPS)
extract and/or silymarin on kidney superoxide dismutase (SOD) in
serum of cyclophosphamide (CP) – treated rats. Values are given
as mean ± SEM for 5 rats in each group. Values with different
superscript letters are significantly different at (P< 0.05).
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polysaccharides (MPS) extract and/or silymarin treated rats
Administration of CP significantly (P< 0.05) increased the
level of malondialdehyde (MDA) and the activity of
glutathione-S-transferase (GST) in the kidney tissue compared
to the control group (Figs. 2 and 5). On the other hand, CP
caused significant decrease (P< 0.05) in reduced glutathione
(GSH) level and superoxide dismutase (SOD) activity com-
pared to the control group (Figs. 3 and 4). Treatment of rats
either with MPS extract (500 and 1000 mg/kg body weight)and/or silymarin significantly increased (P< 0.05) the level
of GSH level. Level of MDA and activity of GST significantly
decreased following treatment of rats either with MPS extract
(500 and 1000 mg/kg body weight) and/or silymarin (Figs. 2
and 5). Administration of MPS extracts (500 mg/kg body
weight) and/or silymarin significantly increased the activities
of SOD (Fig. 4). On the other hand treatment with MPS
extracts (1000 mg/kg body weight) and/or silymarin failed to
increase the SOD activity (Fig. 4).Kidney histopathological analysis
Representative views of kidney sections are shown in (Fig. 6).
As shown in tissue sections stained with hematoxylin and
eosin, CP caused dilation and congestion of renal blood vessel,
vacuolations of epithelial lining renal tubules and atrophy of
glomerular tuft (Fig. 6B–D). It can also be noticed protein cast
in the lumen of renal tubules. Oral administrations of MPS
extract (500 and 1000 mg/kg body weight) and/or silymarin
improved the kidneys architecture compared to the CP group
(Fig. 6E–H).
Discussion
Chemotherapeutic drugs cause renal injury at different levels
and their effect ranges from an elevation in the level of serum
creatinine to renal failure. Among which renal toxicity is a
dreadful complication developed in cancer patients upon
cyclophosphamide (CP) therapy Sinanoglu et al. (2012) and
Rehman et al. (2012). For the therapeutic strategies of renal
injury and disease during CP treatment, it is important to find
complementary antioxidant compound that is able to block
renal injuries. Polysaccharides chemoprevention activity
against cyclophosphamide has been indicated in several
reports Huang et al. (2013), Zhang et al. (2013), Yu et al.
(2014). The present study throws light for the first time on
the therapeutic effect of M. indica polysaccharides (MPS)
and/or silymarin against nephrotoxicity induced by CP in rats.
During the progression of the renal disease, loss of kidney
function is accompanied by failing organ function leading to
accumulation of a series of compounds Vanholder et al.
(2008). Hepatorenal syndrome is most frequently first diag-
nosed by a finding of increasing concentrations of serum crea-
tinine or blood urea nitrogen (BUN) Gine‘ s et al. (2003). The
marked increase in the levels of serum urea and creatinine is a
marker for the nephrotoxicity and kidney damage Cagler et al.
(2002). In consistent with the finding of Cagler et al. (2002) and
Rehman et al. (2012), the results of the present investigation
showed significant increase in the serum urea and creatinine
following CP administration. Creatinine is an endogenous sub-
stance produced by muscle from creatine and creatine phos-
phate, with a rate of production proportionate to the muscle
mass Kurniawan et al. (2013). The measurement of serum cre-
atinine proves useful in diagnosing renal failure and diseases
where, directly proportional relationship exists between crea-
tinine levels and renal function Sharma (2011). This increase
in serum creatinine may be due to the hepatic damage which
evolved into a stage with features of hepatorenal syndrome
Arroyo and Jimenez (2000) including reduction in creatinine
clearance and low glomerular filtration rate Briglia and
Anania (2002).
Figure 6 Photomicrographs of hematoxylin-eosin stained kidney histology of male albino rats (400 magnifications). (A) Kidney
section from control group shows normal histological structure of renal parenchyma with normal structure of glomerulus. (B) Kidney
section from CP treated group showing dilation and congestion of renal blood vessel (BV). (C) Kidney section from CP treated group
showing vacuolations of epithelial lining renal tubules and atrophy of glomerular tuft. (D) kidney section from CP treated group showing
protein cast (PC) in the lumen of renal tubules. (E),(F), (G) and (H) showing kidney section from the group treated with MPS (500 and
1000 mg/kg) and/or silymarin showing the regeneration of kidney parenchyma.
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most mammals by the hepatic enzyme, urate oxidase (uricase),
to allantoin, which is mainly excreted by the kidneys (65–75%)
and intestines (25–35%) De Oliveira and Burini (2012). The
significant increase in uric acid following CP administrationin the present study may be due to reduction in glomerular fil-
tration rate and renal urate excretion Vaziri et al. (1995).
Hyperuricemia also may result from increased net tubular
absorption. After filtration, uric acid undergoes both reabsorp-
tion and secretion in the proximal tubule, and this process is
160 A.I. Amien et al.mediated by a urate/anion exchanger and a voltage sensitive
urate channel Leal-Pinto et al. (1999) and Enomoto et al.
(2002). In consonance with the finding of Yang et al. (2015),
the present study showed a significant decrease in the serum
creatinine, urea and uric acid following treatment with MPS
(500, 1000 mg/kg) and/or silymarin that may be a contributory
self-healing mechanism restoring the kidney structure and
function.
Oxidative stress mediates a wide range of renal impairments
Ebrahimi et al. (2013) and Park et al. (2013). Reactive oxygen
species (ROS) could be renotoxic consequently impairing the
functional capacity of the kidney. Some anti-cancer drugs
including CP are known to exert their cytotoxic effects by a
free radical mediated mechanism Dumontet et al. (2001). Lipid
peroxidation is a free radical induced process leading to oxida-
tive deterioration of poly unsaturated fatty acid. It comes from
the reaction of free radicals with lipids and considered to be an
important feature of the cellular injury brought by free radical
attack Hoek and Pastorino (2002). Malondialdehyde (MDA)
is the one of end products of lipid peroxidation and measure
of free radical generation Sundaram and Murugesan (2011).
In conjunction with the reports of Ayhanci et al. (2010) and
Jnaneshwari et al. (2012), MDA level increased significantly
in the kidney tissue of CP-treated rats as a result of lipid per-
oxidation and nephrotoxicity. It is observed that MPS and
silymarin provided a significant protection against CP-
induced nephrotoxicity by decreasing the level of MDA.
Reduced glutathione (GSH) is a major constituent of the
detoxification pathways. The amino acid constituent cysteine
of GSH and proteins is regarded as being the first line of
defense, and neutralizes the hydroxyl radical and plays an
important role against inflammation and oxidative stress
Circu and Aw (2011) The high electron-donating capacity of
the SH group of cysteine provides great reducing power and
is used to regulate a complex thiol-exchange system. In agree-
ment with the reports of Atessahin et al. (2005) and Ayhanci
et al. (2010), the GSH level in the kidney tissues treated with
CP significantly decreased which may be due to the nephrotox-
icity and accumulation of free radicals. Treatment with MPS
and silymarin shows significant increase in the level of GSH
which may be due its antioxidant effect.
Superoxide dismutase (SOD) is the first antioxidant enzyme
to deal with oxyradicals by accelerating the dismutation of
superoxide to hydrogen peroxide. Catalase (CAT) is a peroxi-
somal hem protein that catalyzes the removal of hydrogen per-
oxide formed during the reaction catalyzed by SOD. Thus,
SOD and CAT act as mutually supportive antioxidative
enzymes that provide protective defense against ROS Cohen
et al. (1978). Viewed in conjunction the finding of Jayaraman
et al. (2008), the present study shows significant decrease in
the level of SOD in the kidney of CP treated rats. The
enhanced free radical concentration resulting from the oxida-
tive stress conditions can cause loss of enzymatic activity
Sanzgiri et al. (1997). However, treatment with MPS in the
present study restored the activity of the studied SOD.
Glutathione-S-transferase (GST) is an enzyme that partici-
pates in the detoxification process due to conjugation reaction
between GSH and xenobiotics Adang et al. (1990). In consis-
tence with the results of Yousefipour et al. (2005), the present
study indicates a significant increase in GST activity following
CP administration. An increase in GST activity might be a
physiological response to increased free radical level. Sinceglutathione is utilized by the body to detoxify xenobiotics
and remove free radicals through its direct antioxidant effect,
the toxic levels of acrolein stimulate induction of GST activity,
thereby depleting GSH and causing direct damage to the
vasculature due to free radical accumulation Yousefipour
et al. (2005). However, treatment with MPS normalized the
GST level through its antioxidant effect that has the ability
to scavenge free radicals.
In conclusion, the present study showed that MPS had
positive antioxidant effect against CP-induced oxidative stress
in the kidney tissues, as it alleviates the alterations in urea,
creatinine and uric acid levels as well as the oxidative stress
markers in the kidney tissues (MDA, GSH, SOD and GST).
In addition, combining MPS with silymarin showed more
pronouncement effect than each one individually. It is worth
to be mentioned that MPS (500 and 1000 mg/kg body weight)
and silymarin treatments restore the MDA and GSH nearly to
control levels.References
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